Mankind Pharma Ltd Financial Flexibility Index
Mankind Pharma Ltd financial flexibility index. Mankind Pharma Ltd (MANKIND) has a Financial Flexibility Index of 0.14x as of September 2025. Free cash flow of Rs19.08 Billion (operating CF Rs16.37 Billion minus capex Rs2.71 Billion) represents 0% of total liabilities (Rs132.85 Billion). Explore reinvestment intensity of Mankind Pharma Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Mankind Pharma Ltd (2019–2026)
Financial flexibility index of Mankind Pharma Ltd from 2019 to 2026. Historical Financial Flexibility Index trend for Mankind Pharma Ltd across 8 annual periods. Check cash flow reinvestment rate of Mankind Pharma Ltd to assess the company's total reinvestment commitment from operating cash flow.
Mankind Pharma Ltd Financial Flexibility Index by Year (2019–2026)
Mankind Pharma Ltd financial flexibility index by year from 2019 to 2026. Year-by-year free cash flow to debt coverage for Mankind Pharma Ltd. For the full cash flow conversion analysis, see Mankind Pharma Ltd (MANKIND) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (INR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.27x | Rs31.42 Billion | Rs25.16 Billion | Rs115.18 Billion | ▲ +25.2% |
| 2025 | 0.22x | Rs28.74 Billion | Rs24.13 Billion | Rs131.91 Billion | ▼ -79.5% |
| 2024 | 1.06x | Rs25.35 Billion | Rs21.52 Billion | Rs23.87 Billion | ▼ -17.1% |
| 2023 | 1.28x | Rs26.45 Billion | Rs18.13 Billion | Rs20.67 Billion | ▲ +11.0% |
| 2022 | 1.15x | Rs32.65 Billion | Rs9.20 Billion | Rs28.31 Billion | ▲ +20.1% |
| 2021 | 0.96x | Rs14.50 Billion | Rs11.37 Billion | Rs15.10 Billion | ▲ +3.7% |
| 2020 | 0.93x | Rs12.98 Billion | Rs10.70 Billion | Rs14.02 Billion | ▲ +16.6% |
| 2019 | 0.79x | Rs8.98 Billion | Rs6.00 Billion | Rs11.31 Billion | — |